Survival analysis of HER2 receptor negative and HER2 receptor low breast cancer patients at a Philippine hospital

被引：0
|
作者：
Arenos, C. C. [1 ]
San Juan, M. [1 ]
Lim, S. [1 ]
Lominoque, A. [1 ]
Reveldez, I. [1 ]
Sison-DImaano, A. [1 ]
Pangandaman, N. [1 ]
Tatoy, V. [1 ]
Uy, T. [1 ]
机构：
[1] Univ Philippines, Div Med Oncol, Dept Med, Philippine Gen Hosp, Manila, Philippines
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.07.460
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P85-2
引用
收藏
页码：S1390 / S1390
页数：1
相关论文
共 50 条
  • [41] Survival of metastatic hormone receptor (HR) positive/HER2 negative; HER2+; and triple negative (TN) breast cancer based on initial presentation
    den Brok, Wendie-Lou D.
    Speers, Caroline
    Lovedeep, Gondara
    Baxter, Emily
    Tyldesley, Scott
    Caroline, Lohrisch
    CANCER RESEARCH, 2015, 75
  • [42] Impact of hormone receptor and HER2 conversions on survival after neoadjuvant chemotherapy in breast cancer patients
    Ran Feng
    Lihui Pan
    Yarong Yao
    Jinnan Gao
    Xiaojun Zhang
    Oncology and Translational Medicine, 2025, 11 (02) : 73 - 80
  • [43] HER2 Gene Protein Assay Is Useful to Determine HER2 Status and Evaluate HER2 Heterogeneity in HER2 Equivocal Breast Cancer
    Hou, Yanjun
    Nitta, Hiroaki
    Li, Zaibo
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2017, 147 (01) : 89 - 95
  • [44] HER2 status in breast cancer patients: A comparison between borderline positive HER2 and strongly positive HER2 tumors
    Huszno, J.
    Nowara, E.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S137 - S137
  • [45] HER2 low and ER low breast cancer
    Schnitt, Stuart
    JOURNAL OF PATHOLOGY, 2023, 261 (SUPPL1): : S7 - S7
  • [46] Prognostic factors in non-metastatic HER2 'low' and HER2 'negative' breast cancer: single institute experience
    Turkel, Alper
    Dogan, Mutlu
    Sertesen, Elif
    Karacin, Cengiz
    Irkkan, Sultan cigdem
    Ates, Ozturk
    WIENER KLINISCHE WOCHENSCHRIFT, 2024, 136 (11-12) : 340 - 346
  • [47] HER2 testing in patients with breast cancer
    Dixon, J. Michael
    Wilson, Victoria
    Verrill, Mark
    Symmans, W. Fraser
    BMJ-BRITISH MEDICAL JOURNAL, 2012, 344
  • [48] HER2 0, HER2 1+and HER2 2+/FISH Negative Breast Cancers Are Biologically Different
    Mon, Khin Su
    Zhang, Hui
    Aragao, Alessa
    Tang, Ping
    LABORATORY INVESTIGATION, 2023, 103 (03) : S182 - S183
  • [49] Targeting Androgen Receptor in Treating HER2 Positive Breast Cancer
    He, Licai
    Du, Zhuanyun
    Xiong, Xusheng
    Ma, Hua
    Zhu, Zhenfeng
    Gao, Hongwei
    Cao, Jiawei
    Li, Tong
    Li, Hongzhi
    Yang, Kaiyan
    Chen, Guorong
    Richer, Jennifer K.
    Gu, Haihua
    SCIENTIFIC REPORTS, 2017, 7
  • [50] Targeting Androgen Receptor in Treating HER2 Positive Breast Cancer
    Licai He
    Zhuanyun Du
    Xusheng Xiong
    Hua Ma
    Zhenfeng Zhu
    Hongwei Gao
    Jiawei Cao
    Tong Li
    Hongzhi Li
    Kaiyan Yang
    Guorong Chen
    Jennifer K. Richer
    Haihua Gu
    Scientific Reports, 7
12345